Literature DB >> 15074633

Association between virulence factors and clinical course of Escherichia coli mastitis.

T Lehtolainen1, T Pohjanvirta, S Pyörälä, S Pelkonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15074633      PMCID: PMC2203302          DOI: 10.1186/1751-0147-44-203

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


× No keyword cloud information.

Introduction

Mastitis caused by Escherichia coli is common in lactating dairy cows. E. coli is considered to be an opportunistic pathogen and originate from a contaminated environment [7]. The severity and course of the disease vary greatly and mainly depend on cow's response [4]. However, the virulence of the bacterial strain involved may also play a role. Bacteria require virulence factors to colonize, multiply and survive in the udder. These include toxins, adhesins, invasins, capsule production and the ability to resist serum complement and scavenge iron. Dominant virulence factors have not been identified in mastitis-derived E. coli isolates [5]. In this study we investigated the association between virulence factors of the isolated bacteria and the clinical course in bovine E. coli mastitis.

Materials and methods

A total of 155 E. coli isolates from acute bovine mastitis was collected during routine farm calls by the ambulatory clinic of the University of Helsinki. The attending veterinarian took aseptically a quarter milk sample for bacterial isolation and determination of milk N-acetyl-β-D-glucosaminidase (NAGase) activity and recorded the clinical signs of the cow and the changes in milk appearance. Mastitis was classified as severe if the cow was depressed and had high fever no appetite, a swollen and painful udder, and substantial changes in the milk appearance. In mild mastitis, cows had no or a slight fever and only moderate changes in the udder and milk. The cows were divided into 3 lactation stage groups: 0–21, 22–210 and over 221 days post partum (p.p.). After 3 to 4 weeks, the follow-up samples were taken for bacterial and milk NAGase analysis; 26 cases missed the resampling. The initial sample was classified as persistent if the second sample had growth of E. coli. The bacteria from the milk samples were identified as E. coli by colony morphology on the blood agar, gram stain, typical growth on eosin-methylene blue (EMB) agar, and by API 20E test (bioMérieux, Marcy l'Etoile, France). Milk NAGase activity was measured using a method described by [6]. Virulence factors and serum resistance were determined as previously described [5]. The association of F17-related fimbriae, S and P fimbriae (grouped together), cytotoxic necrotising factors 1 and 2 (CNF1 and CNF2), aerobactin, TraT, and serum resistance with clinical course of mastitis, NAGase activity, and lactation stage were analysed using the Fisher's exact test, ANOVA, and Pearson's chi square test, respectively. ANOVA and Pearson's chi square test were used also to test associations between the clinical course of mastitis, milk NAGase activity and lactation stage.

Results and discussion

Most of the isolates contained several of the analysed virulence factors. Isolates positive to S and P fimbriae (p < 0.001), CNF1 (p < 0.001), and CNF2 (p < 0.05) were significantly associated with persistent mastitis (Table 1). S and P fimbriae and CNF1, usually found in extraintestinal sources, mostly appeared together in the same isolates [5]. Existence of udder-adapted E. coli strains has been suggested, as the same genotype of E. coli has been isolated in cases of recurrent mastitis [1,2]. The recurrent cases tended to be milder than non-recurrent cases, which could favour chronicity [1]. In our study, the acute stage severity of persistent and non-persistent mastitis did not differ significantly.
Table 1

Association of virulence factors of Escherichia coli isolates from clinical bovine mastitis with clinical signs and persistence of the disease.

Number of isolates with the virulence factor

Type of mastitisF17 n = 14SP1 n = 12CNF12 n = 12CNF22 n = 23AER3 n = 18TraT n = 57Serum resistant n = 91None n = 37
Mild n = 78566108254618
Severe n = 779661310324519
Persistent n = 1616661392
Non-persistent n = 11310441214446431
ND4 n = 263225310184

1 S and P fimbriae

2 Cytotoxic necrotising factor 1 and 2

3 Aerobactin

4 Not determined

Association of virulence factors of Escherichia coli isolates from clinical bovine mastitis with clinical signs and persistence of the disease. 1 S and P fimbriae 2 Cytotoxic necrotising factor 1 and 2 3 Aerobactin 4 Not determined None of the virulence factors was significantly associated with the severity of mastitis. Milk NAGase activity was significantly (p < 0.01) lower in severe than in mild mastitis (221 ± 23 arbitrary units (AU) vs 291 ± 21 AU). The isolates positive to S and P fimbriae and CNF1 caused significantly (p < 0.01) higher NAGase (839 ± 48 AU), and F17-positive isolates lower (146 ± 34 AU) NAGase activity as compared with the cases caused by bacteria without these virulence factors, (245 ± 17 AU), and (268 ± 17 AU). The lactation stage was not associated with the presence of any virulence factors or persistence of mastitis, but was significantly (p < 0.05) associated with severity. The clinical signs tended to be milder in early (0–21 d p.p.) than in later lactation, which is contrary to previous studies [3,8]. In field conditions the severity of the signs of mastitis is difficult to determine, as the time of the onset of the mastitis is not known, and the clinical signs change rapidly in E. coli mastitis. In conclusion, some evidence of the association between bacterial factors and different types of E. coli mastitis was shown, but more research is needed.
  8 in total

1.  Adaptation of Escherichia coli to the bovine mammary gland.

Authors:  A J Bradley; M J Green
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Virulence factors of Escherichia coli isolated from bovine clinical mastitis.

Authors:  T Kaipainen; T Pohjanvirta; N Y Shpigel; A Shwimmer; S Pyörälä; S Pelkonen
Journal:  Vet Microbiol       Date:  2002-02-26       Impact factor: 3.293

3.  Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995).

Authors:  S H Pyörälä; E O Pyörälä
Journal:  J Am Vet Med Assoc       Date:  1998-02-01       Impact factor: 1.936

4.  Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis.

Authors:  J Hirvonen; K Eklund; A M Teppo; G Huszenicza; M Kulcsar; H Saloniemi; S Pyörälä
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

5.  Recurrent clinical mastitis caused by Escherichia coli in dairy cows.

Authors:  D Döpfer; H W Barkema; T J Lam; Y H Schukken; W Gaastra
Journal:  J Dairy Sci       Date:  1999-01       Impact factor: 4.034

6.  In vitro comparison of bovine mastitis and fecal Escherichia coli isolates.

Authors:  J Nemeth; C A Muckle; C L Gyles
Journal:  Vet Microbiol       Date:  1994-06       Impact factor: 3.293

7.  The pathogenesis of experimental Escherichia coli mastitis in newly calved dairy cows.

Authors:  A W Hill; A L Shears; K G Hibbitt
Journal:  Res Vet Sci       Date:  1979-01       Impact factor: 2.534

8.  Milk plasmin, N-acetyl-beta-D-glucosaminidase, and antitrypsin as determinants of bacterial replication rates in whey.

Authors:  T Mattila; M Sandholm
Journal:  J Dairy Sci       Date:  1986-03       Impact factor: 4.034

  8 in total
  5 in total

1.  No evidence for a bovine mastitis Escherichia coli pathotype.

Authors:  Andreas Leimbach; Anja Poehlein; John Vollmers; Dennis Görlich; Rolf Daniel; Ulrich Dobrindt
Journal:  BMC Genomics       Date:  2017-05-08       Impact factor: 3.969

2.  Distribution of CRISPR in Escherichia coli Isolated from Bulk Tank Milk and Its Potential Relationship with Virulence.

Authors:  Hyo-Jung Kang; Young-Ju Lee
Journal:  Animals (Basel)       Date:  2022-02-17       Impact factor: 2.752

3.  Shiga toxin-producing Escherichia coli isolated from bovine mastitic milk: serogroups, virulence factors, and antibiotic resistance properties.

Authors:  Hassan Momtaz; Farhad Safarpoor Dehkordi; Taghi Taktaz; Amir Rezvani; Sajad Yarali
Journal:  ScientificWorldJournal       Date:  2012-11-19

4.  Genomic Comparative Study of Bovine Mastitis Escherichia coli.

Authors:  Florent Kempf; Cindy Slugocki; Shlomo E Blum; Gabriel Leitner; Pierre Germon
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

5.  Cloning, Expression, and Immunogenicity of Fimbrial-F17A Subunit Vaccine against Escherichia coli Isolated from Bovine Mastitis.

Authors:  Wei Chen; Yongxia Liu; Jinhua Yin; Youtian Deng; Tariq Ali; Ju Zhang; Jia Cheng; Sadeeq Ur Rahman; Jian Gao; Bo Han
Journal:  Biomed Res Int       Date:  2017-11-29       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.